论文信息 - P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions - 字舞流文

P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions

A. Bar-Or | H. Hartung | T. Derfuss | S. Hauser | R. Hughes | J. Eggebrecht | H. Koendgen | Q. Wang | A. Sauter | H. Koendgen | M. Weber | Qing Wang | H.-P. Hartung | S. L. Hauser | Amit Bar-Or | Tobias Derfuss | Martin S. Weber